Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 411
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist Care 2023 Morieri M. L.Fadini G. P.Bonora B. M. + DIABETES THERAPY - -
Effectiveness of adding alarms to flash glucose monitoring in adults with type 1 diabetes under routine care 2022 Boscari F.Ferretto S.Fadini G. P.Avogaro A.Bruttomesso D. + ACTA DIABETOLOGICA - -
Glucose-lowering drugs with cardiovascular benefits as modifiers of critical elements of the human life history 2022 Avogaro, Angelode Kreutzenberg, Saula VigiliMorieri, Mario LucaFadini, Gian Paolo + THE LANCET DIABETES & ENDOCRINOLOGY - -
A miR-125/Sirtuin-7 pathway drives the pro-calcific potential of myeloid cells in diabetic vascular disease 2022 Vigili de Kreutzenberg, SaulaGiannella, AlessandraCeolotto, GiulioFaggin, ElisabettaCappellari, RobertaMazzucato, MartaFraccaro, ChiaraTarantini, GiuseppeAvogaro, AngeloFadini, Gian Paolo DIABETOLOGIA - -
Hyperglycemia, Reduced Hematopoietic Stem Cells, and Outcome of COVID-19 2022 Bonora, Benedetta MariaFogar, PaolaZuin, JennyFalaguasta, DanieleCappellari, RobertaCattelan, AnnamariaMarinello, SerenaAvogaro, AngeloPlebani, MarioBasso, DanielaFadini, Gian Paolo + DIABETES - -
Hematopoietic progenitor cell liabilities and alarmins S100A8/A9-related inflammaging associate with frailty and predict poor cardiovascular outcomes in older adults 2022 Bonora B. M.Fadini G. P.Casciaro F.Cappellari R.Giorgio M. + AGING CELL - -
The effect of GLP-1 receptor agonists on N-terminal pro-brain natriuretic peptide. A scoping review and metanalysis 2022 Avogaro A.Azzolina D.Gregori D.De Kreutzenberg S.Fadini G. P. + INTERNATIONAL JOURNAL OF CARDIOLOGY - -
Hematopoietic and Nonhematopoietic p66Shc Differentially Regulates Stem Cell Traffic and Vascular Response to Ischemia in Diabetes 2022 Albiero, MattiaD'Anna, MariannaBonora, Benedetta MariaZuccolotto, GaiaRosato, AntonioGiorgio, MarcoIori, ElisabettaAvogaro, AngeloFadini, Gian Paolo ANTIOXIDANTS & REDOX SIGNALING - -
Efficacy of Dapagliflozin in Southern Europe Across the Spectrum of Characteristics of Type 2 Diabetes: An International Real-World Analysis 2022 Fadini, Gian Paolo + DIABETES, METABOLIC SYNDROME AND OBESITY - -
Time-resolved trajectory of glucose lowering medications and cardiovascular outcomes in type 2 diabetes: a recurrent neural network analysis 2022 Longato E.Di Camillo B.Sparacino G.Avogaro A.Fadini G. P. CARDIOVASCULAR DIABETOLOGY - -
In hospital risk factors for acute kidney injury and its burden in patients with Sars-Cov-2 infection: a longitudinal multinational study 2022 Morieri M. L.Ronco C.Avogaro A.Farnia F.Vianello A.Fadini G. P.Vettor R.Fioretto P. + SCIENTIFIC REPORTS - -
Impaired haematopoietic stem / progenitor cell traffic and multi-organ damage in diabetes 2022 Fadini, Gian Paolo + - - -
IDegLira for the Real-World Treatment of Type 2 Diabetes in Italy: Protocol and Interim Results from the REX Observational Study 2022 Fadini, Gian Paolo + DIABETES THERAPY - -
Mannose Receptor Deficiency Impacts Bone Marrow and Circulating Immune Cells during High Fat Diet Induced Obesity 2022 Fadini G. P.Albiero M. + METABOLITES - -
Management of type 2 diabetes with a treat-to-benefit approach improved long-term cardiovascular outcomes under routine care 2022 Morieri, Mario LucaLongato, EnricoDi Camillo, BarbaraSparacino, GiovanniAvogaro, AngeloFadini, Gian Paolo CARDIOVASCULAR DIABETOLOGY - -
The IGFBP3/TMEM219 pathway regulates beta cell homeostasis 2022 Amabile G.Fadini G. P.Del Prato S. + NATURE COMMUNICATIONS - -
Semisolid Wet Sol–Gel Silica/Hydroxypropyl Methyl Cellulose Formulation for Slow Release of Serpin B3 Promotes Wound Healing In Vivo 2022 Albiero, MattiaVillano, GianmarcoBiasiolo, AlessandraQuarta, SantinaBernardotto, SimoneRuvoletto, MariagraziaFadini, Gian PaoloPontisso, PatriziaMorpurgo, Margherita + PHARMACEUTICS - -
Comparative effectiveness and safety of glargine 300 U/mL versus degludec 100 U/mL in insulin-naïve patients with type 2 diabetes. A multicenter retrospective real-world study (RESTORE-2 NAIVE STUDY) 2022 Fadini, Gian Paolo + ACTA DIABETOLOGICA - -
Infection Rates and Impact of Glucose Lowering Medications on the Clinical Course of COVID-19 in People with Type 2 Diabetes: A Retrospective Observational Study 2022 Lapolla, AnnunziataGiron, Maria CeciliaAvogaro, AngeloFadini, Gian Paolo + DIABETES, METABOLIC SYNDROME AND OBESITY - -
Glycaemic Control Achieves Sustained Increases of Circulating Endothelial Progenitor Cells in Patients Hospitalized for Decompensated Diabetes: An Observational Study 2022 Bonora, Benedetta MariaCappellari, RobertaGrasso, MarcoMazzucato, MartaD'Anna, MariannaAvogaro, AngeloFadini, Gian Paolo DIABETES THERAPY - -
Mostrati risultati da 21 a 40 di 411
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile